Key result
A rare case of malignant fibrous histiocytoma in the maxillofacial region is reported, highlighting the importance of considering it in the differential diagnosis of head and neck tumors.
Case Report (n=1)
Highlights the importance of considering malignant fibrous histiocytoma in the differential diagnosis of head and neck tumors due to its poor prognosis.
Rare maxillofacial tumor reports heighten diagnostic vigilance; extends sparse literature but leaves management standards unresolved.
Malignant fibrous histiocytoma (MFH) is the most common soft-tissue sarcoma, but is relatively uncommon in the head and neck area. This tumor is difficult to distinguish histologically from other sarcomas and carcinomas. The most reliable treatment for MFH is surgery. Prognosis is poor and recurrence and local metastasis are common. In comparison with MFH of the extremities and trunk, the 5-year survival rate for cases of this tumor in the head and neck region is low. It is important to consider MFH in the differential diagnosis of head and neck tumors because of its poor prognosis. We report such a rare case in the rare site of maxillofacial region.
No takes yet. Share an insight, caveat, or question.
Sridhar et al. (2014) conducted a case report in Malignant fibrous histiocytoma (n=1). A rare case of malignant fibrous histiocytoma in the maxillofacial region is reported, highlighting the importance of considering it in the differential diagnosis of head and neck tumors.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: